Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Population pharmacokinetics. A regulatory perspective.

H Sun1, E O Fadiran, C D Jones

  • 1Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland, USA. sunh@cder.fda.gov

Clinical Pharmacokinetics
|August 19, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methane removal and the proportional reductions in surface temperature and ozone.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2021
Same author

Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
Same author

Development of operational immunologic tolerance with neonatal gene transfer in nonhuman primates: preliminary studies.

Gene therapy·2015
Same author

Co-dependence of genotype and dietary protein intake to affect expression on amino acid/peptide transporters in porcine skeletal muscle.

Amino acids·2015
Same author

Mic60/Mitofilin determines MICOS assembly essential for mitochondrial dynamics and mtDNA nucleoid organization.

Cell death and differentiation·2015
Same author

Nano-level position resolution for particle tracking in digital in-line holographic microscopy.

Journal of microscopy·2015

Population pharmacokinetic approaches are vital for drug development, identifying variability in drug safety and efficacy. Nonlinear mixed-effects modeling offers a flexible method for analyzing sparse data, crucial for regulatory submissions.

Area of Science:

  • Pharmacometrics
  • Drug Development
  • Clinical Pharmacology

Background:

  • Population approaches are recommended by the US Food and Drug Administration (FDA) for drug development.
  • Population pharmacokinetic (and pharmacodynamic) techniques identify sources of variability impacting drug safety and efficacy.
  • Understanding inter- and intra-individual variability is key to optimizing drug therapy.

Purpose of the Study:

  • To review population pharmacokinetic (PK) modeling approaches for drug development.
  • To discuss the 2-stage estimation method and comprehensively review nonlinear mixed-effects modeling (NLMEM).
  • To highlight practical design considerations and documentation requirements for population PK studies.

Main Methods:

  • The article contrasts the 2-stage approach with nonlinear mixed-effects modeling (NLMEM).

Related Experiment Videos

  • NLMEM is presented as a method applicable even with sparse or limited sampling data.
  • Key aspects covered include study design, data assembly, real-time analysis, and model validation.

    • Main Results:

    • NLMEM provides a robust framework for analyzing population PK data, especially when extensive sampling is not feasible.
    • Real-time data assembly and analysis aid in protocol compliance and error detection.
    • A structured approach involving exploratory data analysis, model development, and validation is essential for reliable results.

    Conclusions:

    • Population pharmacokinetic studies, particularly using NLMEM, are integral to modern drug development and regulatory submissions.
    • Rigorous study design, data management, and validation are critical for 'good pharmacometric practice'.
    • Effective population PK analysis supports informed decision-making for drug safety and efficacy.